Bergman, Mats A.; Rudholm, Niklas - In: Journal of Industrial Economics 51 (2003) 4, pp. 455-467
We study actual and potential competition and other factors that determine price paths of brand-name drugs in the Swedish pharmaceuticals market. The results indicate that the price of the incumbent product is lowered by potential competition, entry of (additional) generics, and the introduction...